Elevance Health (ELV) Stock: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$434.13
-6.05 (-1.37%)
▼
5d:
+1.41%
30d:
+7.88%
90d:
+14.45%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 21, 2026
0d
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$509.93
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$316.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $434.13, which is considered extended relative to its 30-day fair value range of $394.23 to $425.60. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.7) compared to its historical average (12.7). At these levels, the market is pricing in 5.0% annual earnings growth.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $397.12, while resistance sits at $450.69.
Market Sentiment: ELV scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $397.12, while resistance sits at $450.69.
Market Sentiment: ELV scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$394.23 -
$425.60
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($451.71)
- BULLISH: Expecting earnings turnaround to 5.0% growth with 1.4% revenue growth
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$394.23 -
$425.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$397.12
Resistance Level
$450.69
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.67
Wall Street Target
$451.71
(+4.1%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
-13.1%
Profit Margin
2.5%
Valuation Premium vs History
+5.0% premium
PE vs Historical
14.7 vs 12.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.0%
(market-implied from PE analysis)
1-Year Target
$455.84
(+5%)
2-Year Target
$478.63
(+10%)
3-Year Target
$502.56
(+16%)
3-Yr Target (if PE normalizes)
(PE: 15→13)
PE COMPRESSION
$435.18
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.6%)
$753.93
(+74%)
Base:
(SPY PE: 14.7, Growth: 8.6%)
$556.77
(+28%)
Bear:
(PE: 12.5, Growth: 8.6%)
$473.26
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 19.49 | Current EPS (TTM): $22.59
Bull Case
$634.45
(+46%)
Analyst growth 31.0%, PE expands to 21.4
Base Case
$576.78
(+33%)
Market implied 31.0%, PE stable at 19.5
Bear Case
$299.32
(-31%)
Severe decline -20.0%, PE contracts to 16.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 8:13 AM ET
Data refreshes hourly during market hours. Next update: 9:13 AM
Data refreshes hourly during market hours. Next update: 9:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 37 SELL |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 32 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 40 HOLD |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 25 SELL |
|
PGNY
Progyny Inc |
STRONG BUY
12 analysts |
$34 | 50 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
